KLP Kapitalforvaltning’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$608K Hold
35,100
﹤0.01% 1422
2026
Q1
$436K Buy
35,100
+1,600
+5% +$21.5K ﹤0.01% 1485
2025
Q4
$422K Sell
33,500
-3,600
-10% -$41.2K ﹤0.01% 1494
2025
Q3
$371K Hold
37,100
﹤0.01% 1548
2025
Q2
$300K Buy
37,100
+9,400
+34% +$70.9K ﹤0.01% 1602
2025
Q1
$232K Hold
27,700
﹤0.01% 1680
2024
Q4
$219K Buy
+27,700
New +$232K ﹤0.01% 1780

Other funds holding AMRX

KLP Kapitalforvaltning's AMRX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 35,100 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

KLP Kapitalforvaltning first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • KLP Kapitalforvaltning held 35,100 shares of Amneal Pharmaceuticals worth $608K as of Q2 2026.
  • KLP Kapitalforvaltning left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1422 holding.
  • KLP Kapitalforvaltning first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.